[Sponsored] There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit. The post These Are the Top-Rated Autism Therapy Centers in Texas appeared first on MedCity News.
This new standard was developed to address the rise of telehealth, cybersecurity risks/compliance in ePrescribing, data needs, AI, and the growing demand for patient transparency. So what is the Standard solving for, and what can providers expect? The post What Providers Need to Know About the Coming NCPDP Transition appeared first on MedCity News.
When transportation is integrated into the care continuum, everyone benefits: costs go down, appointments stay on track and beneficiaries receive the consistent care they deserve. This transformation isn’t just about speed; it’s about making every ride count. The post Why a Next Generation NEMT Infrastructure is Reshaping Healthcare Access appeared first on MedCity News.
[Sponsored] In an interview, Abarca Chief Information Officer Serge Perras discussed how Abarca is implementing AI and where he sees the most value for PBMs. The post AI Is at the Heart of PBM Evolution appeared first on MedCity News.
Mount Sinai researchers found that popular AI chatbots like ChatGPT and DeepSeek R1 can generate convincing but false medical information when given even a single fabricated term in a prompt. While the study underscored the need for stronger safeguards, its lead author noted that generative AI still holds major promise for reducing clinician workload if…
Navitus Health Solutions is launching a cost-plus pricing model through Costco Pharmacy. It will become available for clients starting in January for prescriptions filled at retail and mail order locations. The post Navitus, Costco Pharmacy Team Up for Cost-Plus Pricing Model appeared first on MedCity News.
Boehringer-Ingelheim pill Hernexeos was awarded accelerated FDA approval for advanced cases of non-small cell lung cancer with HER2 mutations. But Bayer is on its heels with an oral small molecule currently under FDA review in the same indication. The post FDA Nod Makes Boehringer Ingelheim Drug an Alternative to AstraZeneca ADC in Lung Cancer appeared…
As CMS ramps up its RADV initiatives in the months ahead, plans should ensure their risk adjustment programs meet the highest standards of accuracy and compliance. Prospective and retrospective analytics enhanced by AI can help plans work with providers to optimize documentation at the point of care and identify coding errors during audit preparation. The…
Our industry must guard against the weaponization of supply chain resilience in healthcare purchasing. The post Health Systems’ Escalating Demands for Supply Chain Resilience Have Become Counterproductive appeared first on MedCity News.
Exact Sciences is paying $75 million up front for U.S. rights to a colorectal cancer blood test developed by rival Freenome. If approved, Freenome’s liquid biopsy will compete with a blood test from Guardant Health. The post Exact Sciences Teams Up With Freenome to Take on Guardant Health in Colorectal Cancer Screening appeared first on…